Nachrichten zur Pfizer Inc. Aktie

UPDATE 1-Pfizer CEO says there will be no generic Paxlovid for China

...(Adds details from CEO Bourla) Jan 9 (Reuters) - Pfizer Inc... on Monday. Reuters reported on Friday that China was in talks…

Pfizer Says Partner in China Is Gearing up for Paxlovid Sales

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer not in talks on licensing generic COVID pill in China

...NEW YORK (Reuters) - Pfizer Inc Chief Executive Albert Bourla......…

This Censorious Pfizer Board Member Was A Major Influence On Lockdowns

This Censorious Pfizer Board Member Was A Major Influence On Lockdowns …

Pfizer projects up to $84B non COVID revenue in 2030

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer working to send COVID pill Paxlovid to China - CNBC

...(Reuters) - Pfizer Inc is working with Chinese authorities... to a Reuters request for comment on…

Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly

Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) reduced hospitalizations among older patients. read…

UPDATE 1-U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication

... (Reuters) - The U.S. Supreme Court on Monday turned away Pfizer Incs......…

U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication

...WASHINGTON (Reuters) - The U.S. Supreme Court on Monday turned......…

This Stock Could Be a Surprise Growth Pick for 2023

Pfizer is about to enter a whole new era of growth....…

Pfizer Rejected by CN Medical Insurance Drug Catalogue due to High Price; CN in Talks About Producing Paxlovid Generic Drug

The negotiation on the 2022 National Medical Insurance Drug Catalogue has officially concluded yesterday (8th), China's National Healthcare Security Administration…

It’s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer.

With rates rising, biotech has faded. Investors have favored the pharma stalwarts. Bank of America’s drug analyst Geoff Meacham runs…

Exclusive-China in talks with Pfizer for generic COVID drug - sources

...By Julie Zhu and Kevin Huang HONG KONG/BEIJING (Reuters) - China... told Reuters. Chinas medical products regulator -…

Pfizer, China in discussions to license to generic version of COVID drug Paxlovid

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This September

BioNTech, which worked with Pfizer to build an mRNA Covid vaccine, has partnered with the U.K. to turn the technology…

Pfizer Gets FDA Priority Review of Prevnar 20 for Kids >PFE

Pfizer Gets FDA Priority Review of Prevnar 20 for Kids >PFE...…

UPDATE 1-Pfizer to scale down early-stage rare disease research

...(Changes source, adds Pfizer statement) Jan 5 (Reuters) - U.S. pharma... disease and oncology," a spokesperson said in a statement to Reuters,…

BRIEF-Pfizer Says It Will Be Shifting To Invest In Rare And Benign Hematology And Platforms Such As Gene Editing Through External Innovation On Rare Conditions

...Jan 5 (Reuters) - * PFIZER SAYS WILL BE SHIFTING TO INVEST IN RARE......…

Pfizer could sell some assets, convert others into new companies amid broader refocus

Drug maker Pfizer Inc. could part with or otherwise distance itself from some of its research programs....…

Pfizer to Pull Back on Research Into Rare Disease, Gene Therapy

As part of the shift, the company may sell assets like its gene therapy facility in Durham and a cancer-focused…

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Thursday’s Top Analyst Upgrades and Downgrades: Baidu, BNY Mellon, Corning, Merck, Meta Platforms, Microsoft, Pfizer, Rivian, Target and More

Thursdays top analyst upgrades and downgrades included Baidu, Bank of New York Mellon, Charles Schwab, Corning, Livent, Merck, Meta Platforms,…

Wegen Impf-Flaute - Dermapharm am unteren Ende der Erwartungen

München (Reuters) - Die stark abflauende Nachfrage nach Corona-Impfstoff setzt dem Arzneimittel-Hersteller Dermapharm zu.

Das Unternehmen aus Grünwald bei München…

Pfizer: Downgrade

Charlotte (www.aktiencheck.de) - Rating-Update: Geoff Meacham, Analyst von BofA Securities, stuft die Aktie des Pharma-Giganten Pfizer Inc. (ISIN: US7170811035, WKN: 852009,…

As COVID vaccine and Paxlovid sales decline, analysts want to know what’s next for Pfizer

Bank of America analysts downgraded the stock to neutral from buy...…

Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another

The health care sector held up relatively well in a difficult year for stocks in 2022. On Wednesday, one analyst…

Why Pfizer (PFE) Could Beat Earnings Estimates Again

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Serie: Branchenausblick: Die Pharmaindustrie steht nach dem Corona-Boom vor einer Wachstumsdelle

Der Schub durch Covid-Impfstoffe und Medikamente flaut ab, gleichzeitig läuft für einige Produkte der Patentschutz ab. Novo Nordisk löst Pfizer…

Pfizer (PFE) Gains As Market Dips: What You Should Know

In the latest trading session, Pfizer (PFE) closed at $51.26, marking a +0.04% move from the previous day....…

BioNTech: Bundesregierung bemüht sich, überschüssige Impfstofflieferungen zu reduzieren - Aktienanalyse

Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von BioNTech SE (ISIN: US09075V1026,…

Tuesday’s Top Analyst Upgrades and Downgrades: Ally Financial, Apple, Block, DR Horton, EOG, Ford, Micron, PayPal, Pfizer and More

Tuesdays top analyst upgrades and downgrades included Ally Financial, Apple, Ardelyx, Block, DocuSign, D.R. Horton, Enovix, EOG Resources, Ford, Futu,…

BioNTech: Abnahmeverpflichtung für 375 Millionen Dosen Impfstoff

Deutschland hat sich insgesamt verpflichtet, etwa 375 Millionen Dosen Corona-Impfstoff von BioNTech und dem dazugehörigen amerikanischen Pharma-Partner Pfizer abzunehmen. Das…

Abnahmeverpflichtung für 375 Millionen Dosen Biontech-Impfstoff

BERLIN (dpa-AFX) - Deutschland hat sich insgesamt verpflichtet, etwa 375 Millionen Dosen Corona-Impfstoff von Biontech (BioNTech (ADRs))/Pfizer (Pfizer) abzunehmen. Das…

Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer

DUBLIN, Dec. 30, 2022 /PRNewswire/ -- The "Bronchitis Treatments: Global Markets" report has been added to ResearchAndMarkets.coms offering. This study…

Pfizer: Die Daten der Hämophilie-Gentherapie "konkurrenzfähig" - Aktienanalyse

San Francisco (www.aktiencheck.de) - Pfizer-Aktienanalyse von Analyst Mohit Bansal von Wells Fargo Advisors: Mohit Bansal, Analyst von Wells Fargo Advisors, stuft…

Drugmakers Spent Freely in 2022 to Protect Revenue

Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics....…

China-Developed Covid Pill Matches Paxlovid, Study Shows

A China-developed Covid antiviral pill appeared to be as effective as Pfizer Inc.s Paxlovid with fewer safety concerns, according to…

Pfizer (PFE) Pentavalent Meningitis Jab BLA Gets FDA Acceptance

The FDA assigns a standard review to Pfizers (PFE) BLA for pentavalent meningococcal vaccine candidate (MenABCWY), with a decision expected…

Pfizer Announces Positive Results From Late-stage Study Of Hemophilia B Gene Therapy Candidate

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced positive results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene…

Pfizer’s hemophilia B treatment meets primary endpoint in Phase 3 study

Pfizer Inc. said Thursday that a Phase 3 study of fidanacogene elaparvovec for the treatment of hemophilia B in adult…

Pfizer says hemophilia B gene therapy met key goal in Phase 3 trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer Hemophilia Gene Therapy Hits Goal in Final-Stage Study

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer: FDA Accepts For Review BLA For Pentavalent Meningococcal Vaccine Candidate In Adolescents

NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration accepted for review a Biologics License Application or BLA…

Pfizer: Die Kassen weiter prall gefüllt - M&A-Aktivitäten 2023 auf hohem Niveau erwartet - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…

BioNTech-Partner Pfizer: Umsatz- und Gewinneinbruch erwartet

Der Pharma-Riese hat durch die Corona-Pandemie eine Sonderkonjunktur erfahren. Neben dem Covid-19-Medikament Paxlovid sorgte auch der Vertrieb der Corona-Impfstoffe mit…

4 stocks to watch on Wednesday: Apple, Pfizer and more

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Hormone Replacement Therapy Global Market Report 2022: Merck, Bayer, Pfizer, Abbott, Novartis, Novo Nordisk, Amgen, F. Hoffmann-La Roche & Eli Lilly

DUBLIN, Dec. 28, 2022 /PRNewswire/ -- The "Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation,…

Covid-19: Brazil’s Ministry of Health releases Pfizer vaccine for all children from 6 months to 4 years

Brazils Ministry of Health has decided to extend the use of Pfizers vaccine against the new coronavirus (Covid-19) to all…

Pfizer (PFE) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Pfizer (PFE) closed at $51.13, marking a -1.35% move from the previous day....…